INmune Bio Inc. short interest in 2026
In 2026, INmune Bio Inc.'s disclosed short interest ran from 14.66% of shares outstanding on 15 Jan 2026 to 8.11% on 15 Sep 2026, a change of -6.55 percentage points. The year's high was 15.22% on 30 Jan 2026 and its low 7.57% on 14 Aug 2026, averaging 12.00% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.79 days on 30 Apr 2026. Full history: INmune Bio Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 14.66% (15 Jan 2026)
- End of year
- 8.11% (15 Sep 2026)
- Change
- -6.55 pp
- High
- 15.22% (30 Jan 2026)
- Low
- 7.57% (14 Aug 2026)
- Average
- 12.00%
- Highest days to cover
- 17.79 (30 Apr 2026)
- SEC filings marked
- 3
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 14.66% | 11.39 | |
| 30 Jan 2026 | 15.22% | 13.06 | |
| 13 Feb 2026 | 14.91% | 13.07 | |
| 27 Feb 2026 | 14.32% | 7.65 | |
| 13 Mar 2026 | 12.25% | 5.81 | |
| 31 Mar 2026 | 12.89% | 6.99 | 10-K filed |
| 15 Apr 2026 | 12.67% | 10.07 | |
| 30 Apr 2026 | 13.32% | 17.79 | |
| 15 May 2026 | 13.70% | 5.34 | 10-Q filed |
| 29 May 2026 | 13.88% | 14.38 | |
| 15 Jun 2026 | 13.80% | 11.27 | |
| 30 Jun 2026 | 11.54% | 1.62 | |
| 15 Jul 2026 | 8.97% | 2.21 | |
| 31 Jul 2026 | 8.29% | 6.64 | |
| 14 Aug 2026 | 7.57% | 4.98 | 10-Q filed |
| 31 Aug 2026 | 7.87% | 6.26 | |
| 15 Sep 2026 | 8.11% | 7.78 |
See also: INmune Bio Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.